| immunocompetant | Able to develop an immune response. The opposite of immunodeficient. (12 Dec 1998) |
|---|---|
| immunocompetence | <immunology> The bodys ability to develop an immune response to infection or disease. Immunocompetence is measured to see how well the body can fight off certain disease. Many cancer patients become immunocompromised, where their immune system is not as strong as a healthy person's. (16 Dec 1997) |
| immunocompetent | Able to recognise and act against invading antigens. (09 Oct 1997) |
| immunocomplex | Complexes of antibody and antigen. See: immune complex. (05 Mar 2000) |
| immunocompromised | A condition in which the immune system is not functioning normally. (16 Dec 1997) |
| immunocompromised host | A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. (12 Dec 1998) |
| immunoconglutinin | <protein> Antibodies that react with complement components or their breakdown products. Usually directed against C3b or C4 and found in high titre in patients with rheumatoid arthritis. They are formed in response to infection or injection of antigens. (14 Oct 1997) |
| immunoconjugates | Combinations of diagnostic or therapeutic substances linked with specific immune substances such as immunoglobulins, monoclonal antibodies or antigens. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of drugs and radioisotopes in the chemotherapy and radioimmunotherapy of certain cancers. (12 Dec 1998) |
| immunocyte | <haematology, immunology> A leukocyte that is able to stage an immune response. (09 Oct 1997) |
| immunocytoadherence | <technique> A method for determining cell surface properties, in which immunoglobulin or receptors on the surface of one cell population cause cells with corresponding molecular configurations on their surface to adhere in rosettes around the cells. A process through which specific antibody-forming cells bind to antigenicparticles, forming clusters. (21 Jun 2000) |
| immunocytochemical assay | Involves the computerised assessment of microscopic fields following direct fluorescent antibody, indirect fluorescent antibody or indirect or direct immunoperoxidase analysis of biopsy tissue from the patient. In addition to improved specificity with the removal of operator subjectivity, the quantifiability of results through computer data analysis of colour, intensity and concentration has only begun to be realised. (05 Mar 2000) |
| immunocytochemistry | <technique> Techniques for staining cells or tissues using antibodies against the appropriate antigen. Although in principle the first antibody could be labelled, it is more common (and improves the visualisation) to use a second antibody directed against the first (an antiIgG). This second antibody is conjugated either with fluorochromes or appropriate enzymes for colourimetric reactions or gold beads (for electron microscopy) or with the biotin avidin system, so that the location of the primary antibody and thus the antigen, can be recognised. (18 Nov 1997) |
| immunodeficiency | Inabillity to mount a normal immune response. Immunodeficiency can be due to a genetic disease or acquired as in aids due to HIV. (12 Dec 1998) |
| immunodeficiency disorders | <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy (12 Dec 1998) |
| immunodeficiency syndrome | <syndrome> An immunological deficiency or disorder, of which the chief symptom is an increased susceptibility to infection, the pattern of susceptibility being dependent upon the kind of deficiency. See: immunodeficiency. (05 Mar 2000) |
Synonyms : Immunocompromised Patient, Host, Immunocompromised, Host, Immunosuppressed, Hosts, Immunocompromised, Hosts, Immunosuppressed, Immunocompromised Hosts, Immunocompromised Patients, Immunosuppressed Hosts, Patient, Immunocompromised, Patients, Immunocompromised
Synonyms : Immune Conglutinins, Conglutinins, Immune
Synonyms : Immunoconjugate, Radioimmunoconjugate
Synonyms : BIV, Bovine Immunodeficiency-Like Virus, Bovine Immunodeficiency Like Virus, Bovine Immunodeficiency Viruses, Bovine Immunodeficiency-Like Viruses, Immunodeficiency Viruses, Bovine, Immunodeficiency-Like Virus, Bovine, Immunodeficiency-Like Viruses, Bovine
Synonyms : Feline T-Lymphotropic Virus, Feline Immunodeficiency Viruses, Feline T Lymphotropic Lentivirus, Feline T Lymphotropic Virus, Lentivirus, Feline T-Lymphotropic, T-Lymphotropic Lentivirus, Feline, T-Lymphotropic Virus, Feline
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
아이비글로불린에스주 - 새창
|
녹십자 |
A10203301 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
파토불린SDF주 - 새창
|
Baxter AG |
E03150071 | Immunoglobulin anti-D(Rh) | 전문의약품 | 급여 | 분업예외의약품 |
|
감마글로불린주2ml - 새창
|
녹십자 |
A72000021 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
감마글로불린주10ml - 새창
|
녹십자 |
A72000022 | Immunoglobulin, human | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린주2500mg - 새창
|
녹십자 |
A72000101 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린주1000mg - 새창
|
녹십자 |
A72000111 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린주500mg - 새창
|
녹십자 |
A72000121 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린에스주10ml - 새창
|
녹십자 |
A72000341 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린에스주20ml - 새창
|
녹십자 |
A72000342 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
|
아이비글로불린에스주50ml - 새창
|
녹십자 |
A72000343 | Immunoglobulin, human(폴리에칠렌글리콜처리) | 전문의약품 | 삭제 | 분업예외의약품 |
| immunosuppression |
lowering the body's normal immune response to invasion by foreign substances; can be deliberate (as in lowering the immune response to prevent rejection of a transplanted organ) or incidental (as a side effect of radiotherapy or chemotherapy for cancer)
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| immunochemical |
of or relating to immunochemistry
출처: wordnet.princeton.edu/perl/webwn
|
| immunotherapy |
therapy designed to produce immunity to a disease or to enhance resistance by the immune system
출처: wordnet.princeton.edu/perl/webwn
|
| immunoassay |
identification of a substance (especially a protein) by its action as an antigen; "PSA in the blood can be measured with an immunochemical assay"
출처: wordnet.princeton.edu/perl/webwn
|
| immunochemistry |
the field of chemistry concerned with chemical processes in immunology (such as chemical studies of antigens and antibodies)
출처: wordnet.princeton.edu/perl/webwn
|
| immuno | one of the five major classes of immunoglobulins |
|---|---|
| immuno | one of the five major classes of immunoglobulins |
| immuno | of or relating to immunology |
| immuno | a bodily defense reaction that recognizes an invading substance (an antigen: such as a virus or fungus or bacteria or transplanted organ) and produces antibodies specific against that antigen |
| immuno | of or relating to immunology |
| immuno | a disorder of the immune system |
| immuno | a medical scientist who specializes in immunology |
| immuno | the branch of medical science that studies the body's immune system |
| immuno | the branch of immunology that deals with pathologies of the immune system |
| immuno | a drug that lowers the body's normal immune response |
| immuno | of persons whose immune response is inadequate |
| immuno | lowering the body's normal immune response to invasion by foreign substances |